PEPG: PepGen Inc. Company Short-Term Debt

PEPG (PepGen) - company brandmark

PepGen Inc. possesses scientific recognition in the creation of oligonucleotide agents, implementing robotic peptide synthesis to accelerate preclinical testing. The short-term debt balance helps identify loan vulnerabilities, while the 0.00 level records fresh values. The development of Duchenne muscular dystrophy therapy is protected by patents, however, stringent FDA requirements and the risk of clinical failures create significant barriers to entry.

PEPG PepGen Corp Current Liabilities (04/28/2023 - 10/30/2026)

Comprehensive metric breakdowns and analytics for PepGen Inc (PEPG)

- current quotes and average value forecast:
Price Chart PepGen Corp|PEPG - Fair Value Consensus
- market capitalization information:
Market Value PepGen Inc.|PEPG - Total Enterprise Value
- shareholders' equity book value data:
Net Assets per Single Share PepGen|PEPG - Net Asset Value|Market Capitalization to Book Value Ratio pepgen.com|PEPG - Company Assets
- debt and liquidity details:
Debt to Equity PepGen Inc.|PEPG - Long-Term Liabilities to Equity|Short-Term Debt to Capital PepGen Corp|PEPG - Company Total Indebtedness|Debts to Book Capitalization PepGen Inc.|PEPG - Long-Term Debt|Company Short-Term Debt PepGen|Quick Liquidity Indicator pepgen.com
- earnings and multiples data:
PEPG - Final Profit
Comprehensive company analysis:pepgen.com (PEPG)
Mass-produced product of PepGen Inc

Short-term debts reflect the aggregate of obligations under operating loans and borrowings with a maturity of up to one year, determining the current liquidity and financial stability of PepGen Inc. (PEPG). By analyzing the volume of short-term accounts payable and loans, an investor assesses the financing efficiency of developing therapies for Duchenne muscular dystrophy, which is critically important for a biotech company scaling oligonucleotide delivery technology.

Main competitors

BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Short-Term Debt ACADIA Pharmaceuticals|xenon-pharma.com - Current Liabilities|Company Short-Term Debts VKTX|SUPN - Short-Term Debt|Company Short-Term Debt Catalyst Pharmaceuticals Inc CPRX|DNLI (Denali Corp) - Current Liabilities|Harmony Biosciences - Company Short-Term Debts|Short-Term Indebtedness biohavenpharma.com (BHVN)|AMLX: Company Short-Term Debts|Short-Term Debt Trevi Therapeutics Inc (TRVI)|Company Short-Term Debt Praxis Medicines|Company Short-Term Indebtedness AVXL (Anavex Life Sciences Corp)|Company Current Liabilities CBLL (CeriBell, Inc.)|PRTA (Prothena Corporation plc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ALEC (Alector)|Short-Term Debt Volume Annexon Biosciences (ANNX)|OMER - Company Short-Term Debt|NGNE (Neurogene Therapeutics) - Company Short-Term Indebtedness|ACIU: Company Short-Term Debts|Company Current Liabilities voyagertherapeutics.com|Company Current Liabilities NMRA|Scilex Holding (SCLX) - Short-Term Debt Volume|Company Short-Term Debt Tevogen Bio Holdings, Inc. (TVGN)|ACOG: Current Liabilities|Company Short-Term Debts CGTX (Cognition Therapeutics, Inc.)|inhibikase.com (IKT) - Short-Term Debt|SAVA - Company Short-Term Debt|Current Liabilities ASRT|COYA: Company Short-Term Debts|Short-Term Indebtedness Vistagen VTGN|Company Short-Term Debt Ovid Therapeutics Inc|Company Short-Term Indebtedness ABOS (acumenpharm.com)|Company Short-Term Debts CRVO|ATHE - Short-Term Debt|Clene - Company Current Liabilities|Company Short-Term Debts jupiterneurosciences.com JUNS|RLMD - Company Short-Term Debt|Company Short-Term Loans and Borrowings ANVS (annovisbio.com)|gracetx.com (GRCE) - Company Short-Term Debt|Short-Term Debt Firefly Neuroscience, Inc. (AIFF)|Company Short-Term Debt ANEW Medical|NeuroSense Therapeutics, Ltd. - Current Liabilities|Company Short-Term Debts RVPH|MTVA - Short-Term Debt|Company Short-Term Debt NeurAxis NRXS|HSDT (Helius Medical Technologies, Inc.) - Current Liabilities|Passage Bio Corp - Company Short-Term Debts|Short-Term Indebtedness Neuphoria Therapeutics Inc. (NEUP)|NERV: Company Short-Term Debts|Short-Term Debt athira.com (ATHA)|Company Short-Term Debt Addex Therapeutics Ltd|Company Short-Term Indebtedness ALZN (Alzamend)|Company Current Liabilities CYCN (Cyclerion Therapeutics)|PTIX (protagenic.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts KTTA (Pasithea Therapeutics Corp.)|Short-Term Debt Volume Cortigent Inc (CRGT)|ATXI - Company Short-Term Debt|BCLI (Brainstorm Cell Therapeutics Inc.) - Company Short-Term Indebtedness|CARA: Company Short-Term Debts|Company Current Liabilities Chromocell|Company Current Liabilities ELYM|Intra-Cellular (ITCI) - Short-Term Debt Volume|Company Short-Term Debt Longboard Pharmaceuticals, Inc. (LBPH)|MRNS: Current Liabilities|Company Short-Term Debts NKGN (NKGen)|NeuroBo Pharma (NRBO) - Short-Term Debt|SAGE - Company Short-Term Debt|Current Liabilities SNPX|TRVN: Company Short-Term Debts|Short-Term Indebtedness Vigil Neuroscience, Inc. VIGL|Company Short-Term Debt Anew Medical, Inc.|Company Short-Term Indebtedness CERE (Cerevel Corp)